
Cytomine Corporation SA specializes in digital pathology by providing an open-source software platform for collaborative analysis of multi-gigapixel images. They offer services such as hosting, installation, and configuration, along with custom algorithm development tailored to specific needs. Their focus on education, research, and diagnostics in health and biomedical fields differentiates them in the market, and they have established partnerships with well-known companies for routine diagnostics in hospitals. Their traction includes a growing community of users and clients in academia and healthcare, positioning them as a leader in digital pathology solutions.

Cytomine Corporation SA specializes in digital pathology by providing an open-source software platform for collaborative analysis of multi-gigapixel images. They offer services such as hosting, installation, and configuration, along with custom algorithm development tailored to specific needs. Their focus on education, research, and diagnostics in health and biomedical fields differentiates them in the market, and they have established partnerships with well-known companies for routine diagnostics in hospitals. Their traction includes a growing community of users and clients in academia and healthcare, positioning them as a leader in digital pathology solutions.
What they do: Open-source Cytomine platform for collaborative biomedical image analysis and ML integration; commercial hosting, installation, configuration, and custom algorithm development
Founded / HQ: Founded 2017; Seraing, Liège, Belgium
Legal form: Cooperative with a social purpose (Cytomine SCRL FS / Cytomine Corporation SA)
Founders / leadership: Grégoire Vincke (Co‑Founder, CEO) and Renaud Hoyoux (Co‑Founder, CTO)
Notable funding: Seed round announced Apr 26, 2018; Caring Entrepreneurship Fund listed as lead
Digital pathology and biomedical image analysis
2017
Health / Biomedical Software
Seed round announced; amount not publicly disclosed in provided evidence
“Caring Entrepreneurship Fund led a disclosed seed round in April 2018”